Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60


Human coronavirus 229E encodes a single ORF4 protein between the spike and the envelope genes.

Dijkman R, Jebbink MF, Wilbrink B, Pyrc K, Zaaijer HL, Minor PD, Franklin S, Berkhout B, Thiel V, van der Hoek L.

Virol J. 2006 Dec 28;3:106.


Production and characterization of monoclonal antibodies against the nucleocapsid protein of SARS-CoV.

Fang Y, Pekosz A, Haynes L, Nelson EA, Rowland RR.

Adv Exp Med Biol. 2006;581:153-6. No abstract available.


Coronavirus nucleocapsid protein is an RNA chaperone.

Zúñiga S, Sola I, Moreno JL, Sabella P, Plana-Durán J, Enjuanes L.

Virology. 2007 Jan 20;357(2):215-27. Epub 2006 Sep 18.


Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.

Li W, Wong SK, Li F, Kuhn JH, Huang IC, Choe H, Farzan M.

J Virol. 2006 May;80(9):4211-9. Review. No abstract available.


Close relationship between SARS-coronavirus and group 2 coronavirus.

Kim OJ, Lee DH, Lee CH.

J Microbiol. 2006 Feb;44(1):83-91.


False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV.

Maache M, Komurian-Pradel F, Rajoharison A, Perret M, Berland JL, Pouzol S, Bagnaud A, Duverger B, Xu J, Osuna A, Paranhos-Baccalà G.

Clin Vaccine Immunol. 2006 Mar;13(3):409-14.


Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates.

Liu SJ, Leng CH, Lien SP, Chi HY, Huang CY, Lin CL, Lian WC, Chen CJ, Hsieh SL, Chong P.

Vaccine. 2006 Apr 12;24(16):3100-8. Epub 2006 Feb 8.


SARS-CoV infection in a restaurant from palm civet.

Wang M, Yan M, Xu H, Liang W, Kan B, Zheng B, Chen H, Zheng H, Xu Y, Zhang E, Wang H, Ye J, Li G, Li M, Cui Z, Liu YF, Guo RT, Liu XN, Zhan LH, Zhou DH, Zhao A, Hai R, Yu D, Guan Y, Xu J.

Emerg Infect Dis. 2005 Dec;11(12):1860-5.


Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine.

Qin E, Shi H, Tang L, Wang C, Chang G, Ding Z, Zhao K, Wang J, Chen Z, Yu M, Si B, Liu J, Wu D, Cheng X, Yang B, Peng W, Meng Q, Liu B, Han W, Yin X, Duan H, Zhan D, Tian L, Li S, Wu J, Tan G, Li Y, Li Y, Liu Y, Liu H, Lv F, Zhang Y, Kong X, Fan B, Jiang T, Xu S, Wang X, Li C, Wu X, Deng Y, Zhao M, Zhu Q.

Vaccine. 2006 Feb 13;24(7):1028-34. Epub 2005 Sep 12.


Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63.

Chan KH, Cheng VC, Woo PC, Lau SK, Poon LL, Guan Y, Seto WH, Yuen KY, Peiris JS.

Clin Diagn Lab Immunol. 2005 Nov;12(11):1317-21.


Cross-reaction of SARS-CoV antigen with autoantibodies in autoimmune diseases.

Wang Y, Sun S, Shen H, Jiang L, Zhang M, Xiao D, Liu Y, Ma X, Zhang Y, Guo N, Jia T.

Cell Mol Immunol. 2004 Aug;1(4):304-7.


Bats are natural reservoirs of SARS-like coronaviruses.

Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, Wang H, Crameri G, Hu Z, Zhang H, Zhang J, McEachern J, Field H, Daszak P, Eaton BT, Zhang S, Wang LF.

Science. 2005 Oct 28;310(5748):676-9. Epub 2005 Sep 29.


Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach.

Flego M, Di Bonito P, Ascione A, Zamboni S, Carattoli A, Grasso F, Cassone A, Cianfriglia M.

BMC Infect Dis. 2005 Sep 19;5:73.


Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats.

Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, Wong BH, Wong SS, Leung SY, Chan KH, Yuen KY.

Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5. Epub 2005 Sep 16.


Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms.

Kan B, Wang M, Jing H, Xu H, Jiang X, Yan M, Liang W, Zheng H, Wan K, Liu Q, Cui B, Xu Y, Zhang E, Wang H, Ye J, Li G, Li M, Cui Z, Qi X, Chen K, Du L, Gao K, Zhao YT, Zou XZ, Feng YJ, Gao YF, Hai R, Yu D, Guan Y, Xu J.

J Virol. 2005 Sep;79(18):11892-900. Erratum in: J Virol. 2006 Aug;80(15):7786.


Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43.

Che XY, Qiu LW, Liao ZY, Wang YD, Wen K, Pan YX, Hao W, Mei YB, Cheng VC, Yuen KY.

J Infect Dis. 2005 Jun 15;191(12):2033-7. Epub 2005 May 6.


Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.

Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, Jones LP, Yilla M, Babcock GJ, Greenough T, Ambrosino DM, Alvarez R, Callaway J, Cavitt S, Kamrud K, Alterson H, Smith J, Harcourt JL, Miao C, Razdan R, Comer JA, Rollin PE, Ksiazek TG, Sanchez A, Rota PA, Bellini WJ, Anderson LJ.

J Virol Methods. 2005 Sep;128(1-2):21-8.


Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential.

Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B.

FEBS Lett. 2005 Apr 11;579(10):2130-6.


SARS-associated coronavirus transmitted from human to pig.

Chen W, Yan M, Yang L, Ding B, He B, Wang Y, Liu X, Liu C, Zhu H, You B, Huang S, Zhang J, Mu F, Xiang Z, Feng X, Wen J, Fang J, Yu J, Yang H, Wang J.

Emerg Infect Dis. 2005 Mar;11(3):446-8.

Supplemental Content

Support Center